Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-08
Pages: 175 Pages
Report ld: 6036693
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2026-2032
5.9%
Market Size,2032
USD 3,316
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,351 million
Market Forecast in 2032(Value)
US$ 3,316 million
CAGR
5.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.In 2025, global Hemostats production reached approximately 273 M Unit.
A major driver of the hemostats market is the rising volume of surgical procedures worldwide, especially in cardiovascular, orthopedic, trauma, and general surgeries where rapid bleeding control is critical. As populations age and chronic conditions such as diabetes, cancer, and cardiovascular disease become more common, hospitals perform more complex operations with higher bleeding risk. This increases routine demand for topical hemostats and sealants that help shorten time-to-hemostasis, reduce complications, and support faster patient stabilization.
Another key driver is the growing emphasis on patient safety, blood management, and cost reduction in healthcare systems. Clinicians and providers aim to minimize blood loss, transfusion rates, and re-operation caused by uncontrolled bleeding—outcomes that can significantly increase length of stay and overall treatment costs. Hemostatic agents and adjunctive products are increasingly used as part of standardized surgical protocols to improve efficiency in the operating room and to support enhanced recovery pathways, particularly where reimbursement and quality metrics reward better outcomes.
Innovation and product diversification also propel market growth. Manufacturers are improving performance across different bleeding severities and surgical fields, offering a broader mix of mechanical (gelatin, collagen, oxidized regenerated cellulose), active (thrombin-based), flowable, and combination hemostats as well as sealants for difficult-to-access sites. At the same time, adoption is supported by better usability (ready-to-use formats, faster preparation), compatibility with minimally invasive techniques, and wider availability in ambulatory surgical centers—expanding use beyond large hospitals into more outpatient settings.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Hemostats market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Segment by Application
- Prehospital Treatment
- Hospital Treatment
Segment by Category
- Biodegradable
- Non-biodegradable
Segment by Division
- Online Sales
- Offline Sales
CHAPTER OUTLINE
Chapter 1: Defines the Hemostats study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Hemostats: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hemostats Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Market Segmentation by Feature
1.3.1 Global Hemostats Market Size by Feature, 2021 vs 2025 vs 2032
1.3.2 Biodegradable
1.3.3 Non-biodegradable
1.4 Market Segmentation by Channel
1.4.1 Global Hemostats Market Size by Channel, 2021 vs 2025 vs 2032
1.4.2 Online Sales
1.4.3 Offline Sales
1.5 Market Segmentation by Application
1.5.1 Global Hemostats Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Prehospital Treatment
1.5.3 Hospital Treatment
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Hemostats Revenue Estimates and Forecasts (2021-2032)
2.2 Global Hemostats Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Hemostats Sales Estimates and Forecasts (2021-2032)
2.4 Global Hemostats Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Hemostats Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Hemostats Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Thrombin-Based Hemostats: Market Share by Key Manufacturers
3.5.2 Oxidized Regenerated Cellulose Based Hemostats: Market Share by Key Manufacturers
3.5.3 Combination Hemostats: Market Share by Key Manufacturers
3.5.4 Gelatin Based Hemostats: Market Share by Key Manufacturers
3.5.5 Collagen Based Hemostats: Market Share by Key Manufacturers
3.6 Global Hemostats Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Hemostats Sales Performance by Type
4.1.1 Global Hemostats Sales Volume by Type (2021-2032)
4.1.2 Global Hemostats Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Hemostats Sales Performance by Feature
4.2.1 Global Hemostats Sales Volume by Feature (2021-2032)
4.2.2 Global Hemostats Revenue by Feature (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Feature (2021-2032)
4.3 Global Hemostats Sales Performance by Channel
4.3.1 Global Hemostats Sales Volume by Channel (2021-2032)
4.3.2 Global Hemostats Revenue by Channel (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Channel (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Hemostats Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hemostats Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Hemostats Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Hemostats Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Hemostats Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Hemostats Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Hemostats Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Hemostats Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Hemostats Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Hemostats Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Hemostats Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Hemostats Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Business Overview
11.1.3 Ethicon Hemostats Product Models, Descriptions and Specifications
11.1.4 Ethicon Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Ethicon Hemostats Sales by Product in 2025
11.1.6 Ethicon Hemostats Sales by Application in 2025
11.1.7 Ethicon Hemostats Sales by Geographic Area in 2025
11.1.8 Ethicon Hemostats SWOT Analysis
11.1.9 Ethicon Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hemostats Product Models, Descriptions and Specifications
11.2.4 Pfizer Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Pfizer Hemostats Sales by Product in 2025
11.2.6 Pfizer Hemostats Sales by Application in 2025
11.2.7 Pfizer Hemostats Sales by Geographic Area in 2025
11.2.8 Pfizer Hemostats SWOT Analysis
11.2.9 Pfizer Recent Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Corporation Information
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Hemostats Product Models, Descriptions and Specifications
11.3.4 Baxter International Inc. Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Baxter International Inc. Hemostats Sales by Product in 2025
11.3.6 Baxter International Inc. Hemostats Sales by Application in 2025
11.3.7 Baxter International Inc. Hemostats Sales by Geographic Area in 2025
11.3.8 Baxter International Inc. Hemostats SWOT Analysis
11.3.9 Baxter International Inc. Recent Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Corporation Information
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Hemostats Product Models, Descriptions and Specifications
11.4.4 C. R. Bard Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 C. R. Bard Hemostats Sales by Product in 2025
11.4.6 C. R. Bard Hemostats Sales by Application in 2025
11.4.7 C. R. Bard Hemostats Sales by Geographic Area in 2025
11.4.8 C. R. Bard Hemostats SWOT Analysis
11.4.9 C. R. Bard Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Business Overview
11.5.3 The Medicines Company Hemostats Product Models, Descriptions and Specifications
11.5.4 The Medicines Company Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 The Medicines Company Hemostats Sales by Product in 2025
11.5.6 The Medicines Company Hemostats Sales by Application in 2025
11.5.7 The Medicines Company Hemostats Sales by Geographic Area in 2025
11.5.8 The Medicines Company Hemostats SWOT Analysis
11.5.9 The Medicines Company Recent Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Corporation Information
11.6.2 Anika Therapeutics Business Overview
11.6.3 Anika Therapeutics Hemostats Product Models, Descriptions and Specifications
11.6.4 Anika Therapeutics Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Anika Therapeutics Recent Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Corporation Information
11.7.2 Advanced Medical Solutions Business Overview
11.7.3 Advanced Medical Solutions Hemostats Product Models, Descriptions and Specifications
11.7.4 Advanced Medical Solutions Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Advanced Medical Solutions Recent Developments
11.8 Integra LifeSciences Corporation
11.8.1 Integra LifeSciences Corporation Corporation Information
11.8.2 Integra LifeSciences Corporation Business Overview
11.8.3 Integra LifeSciences Corporation Hemostats Product Models, Descriptions and Specifications
11.8.4 Integra LifeSciences Corporation Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Integra LifeSciences Corporation Recent Developments
11.9 B Braun Melsungen AG
11.9.1 B Braun Melsungen AG Corporation Information
11.9.2 B Braun Melsungen AG Business Overview
11.9.3 B Braun Melsungen AG Hemostats Product Models, Descriptions and Specifications
11.9.4 B Braun Melsungen AG Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 B Braun Melsungen AG Recent Developments
11.10 Gelita Medical GmbH
11.10.1 Gelita Medical GmbH Corporation Information
11.10.2 Gelita Medical GmbH Business Overview
11.10.3 Gelita Medical GmbH Hemostats Product Models, Descriptions and Specifications
11.10.4 Gelita Medical GmbH Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Gelita Medical GmbH Recent Developments
11.11 Equimedical
11.11.1 Equimedical Corporation Information
11.11.2 Equimedical Business Overview
11.11.3 Equimedical Hemostats Product Models, Descriptions and Specifications
11.11.4 Equimedical Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Equimedical Recent Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Corporation Information
11.12.2 Vascular Solutions Business Overview
11.12.3 Vascular Solutions Hemostats Product Models, Descriptions and Specifications
11.12.4 Vascular Solutions Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Vascular Solutions Recent Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Corporation Information
11.13.2 Marine Polymer Technologies Business Overview
11.13.3 Marine Polymer Technologies Hemostats Product Models, Descriptions and Specifications
11.13.4 Marine Polymer Technologies Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Marine Polymer Technologies Recent Developments
11.14 Z-Medica, LLC
11.14.1 Z-Medica, LLC Corporation Information
11.14.2 Z-Medica, LLC Business Overview
11.14.3 Z-Medica, LLC Hemostats Product Models, Descriptions and Specifications
11.14.4 Z-Medica, LLC Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Z-Medica, LLC Recent Developments
11.15 CryoLife
11.15.1 CryoLife Corporation Information
11.15.2 CryoLife Business Overview
11.15.3 CryoLife Hemostats Product Models, Descriptions and Specifications
11.15.4 CryoLife Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 CryoLife Recent Developments
11.16 BioCer Entwicklungs-GmbH.
11.16.1 BioCer Entwicklungs-GmbH. Corporation Information
11.16.2 BioCer Entwicklungs-GmbH. Business Overview
11.16.3 BioCer Entwicklungs-GmbH. Hemostats Product Models, Descriptions and Specifications
11.16.4 BioCer Entwicklungs-GmbH. Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 BioCer Entwicklungs-GmbH. Recent Developments
11.17 Biom'Up SAS
11.17.1 Biom'Up SAS Corporation Information
11.17.2 Biom'Up SAS Business Overview
11.17.3 Biom'Up SAS Hemostats Product Models, Descriptions and Specifications
11.17.4 Biom'Up SAS Hemostats Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Biom'Up SAS Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hemostats Industry Chain
12.2 Hemostats Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hemostats Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hemostats Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hemostats Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Hemostats Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostats Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Hemostats Market Size Growth Rate by Feature, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Hemostats Market Size Growth Rate by Channel, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Hemostats Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Hemostats Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Hemostats Revenue by Region (US$ Million), 2021-2026
Table 7. Global Hemostats Revenue by Region (US$ Million), 2027-2032
Table 8. Global Hemostats Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Pcs)
Table 9. Global Hemostats Sales by Region (K Pcs), 2021-2026
Table 10. Global Hemostats Sales by Region (K Pcs), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Hemostats Sales by Manufacturers (K Pcs), 2021-2026
Table 13. Global Hemostats Sales Share by Manufacturers (2021-2026)
Table 14. Global Hemostats Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Hemostats Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Hemostats Revenue, 2025
Table 18. Global Hemostats Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Hemostats Average Selling Price (ASP) by Manufacturers (US$/Pc), 2021-2026
Table 20. Key Manufacturers Hemostats Manufacturing Base and Headquarters
Table 21. Global Hemostats Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Hemostats Sales Volume by Type (K Pcs), 2021-2026
Table 25. Global Hemostats Sales Volume by Type (K Pcs), 2027-2032
Table 26. Global Hemostats Revenue by Type (US$ Million), 2021-2026
Table 27. Global Hemostats Revenue by Type (US$ Million), 2027-2032
Table 28. Global Hemostats Sales Volume by Feature (K Pcs), 2021-2026
Table 29. Global Hemostats Sales Volume by Feature (K Pcs), 2027-2032
Table 30. Global Hemostats Revenue by Feature (US$ Million), 2021-2026
Table 31. Global Hemostats Revenue by Feature (US$ Million), 2027-2032
Table 32. Global Hemostats Sales Volume by Channel (K Pcs), 2021-2026
Table 33. Global Hemostats Sales Volume by Channel (K Pcs), 2027-2032
Table 34. Global Hemostats Revenue by Channel (US$ Million), 2021-2026
Table 35. Global Hemostats Revenue by Channel (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Hemostats Sales by Application (K Pcs), 2021-2026
Table 38. Global Hemostats Sales by Application (K Pcs), 2027-2032
Table 39. Hemostats High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Hemostats Revenue by Application (US$ Million), 2021-2026
Table 41. Global Hemostats Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Hemostats Growth Accelerators and Market Barriers
Table 45. North America Hemostats Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Hemostats Sales (K Pcs) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Hemostats Growth Accelerators and Market Barriers
Table 48. Europe Hemostats Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Hemostats Sales (K Pcs) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Hemostats Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Hemostats Sales (K Pcs) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Hemostats Growth Accelerators and Market Barriers
Table 53. Southeast Asia Hemostats Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Hemostats Investment Opportunities and Key Challenges
Table 55. Central and South America Hemostats Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Hemostats Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Hemostats Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Ethicon Corporation Information
Table 59. Ethicon Description and Major Businesses
Table 60. Ethicon Product Models, Descriptions and Specifications
Table 61. Ethicon Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 62. Ethicon Sales Value Proportion by Product in 2025
Table 63. Ethicon Sales Value Proportion by Application in 2025
Table 64. Ethicon Sales Value Proportion by Geographic Area in 2025
Table 65. Ethicon Hemostats SWOT Analysis
Table 66. Ethicon Recent Developments
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Major Businesses
Table 69. Pfizer Product Models, Descriptions and Specifications
Table 70. Pfizer Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 71. Pfizer Sales Value Proportion by Product in 2025
Table 72. Pfizer Sales Value Proportion by Application in 2025
Table 73. Pfizer Sales Value Proportion by Geographic Area in 2025
Table 74. Pfizer Hemostats SWOT Analysis
Table 75. Pfizer Recent Developments
Table 76. Baxter International Inc. Corporation Information
Table 77. Baxter International Inc. Description and Major Businesses
Table 78. Baxter International Inc. Product Models, Descriptions and Specifications
Table 79. Baxter International Inc. Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 80. Baxter International Inc. Sales Value Proportion by Product in 2025
Table 81. Baxter International Inc. Sales Value Proportion by Application in 2025
Table 82. Baxter International Inc. Sales Value Proportion by Geographic Area in 2025
Table 83. Baxter International Inc. Hemostats SWOT Analysis
Table 84. Baxter International Inc. Recent Developments
Table 85. C. R. Bard Corporation Information
Table 86. C. R. Bard Description and Major Businesses
Table 87. C. R. Bard Product Models, Descriptions and Specifications
Table 88. C. R. Bard Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 89. C. R. Bard Sales Value Proportion by Product in 2025
Table 90. C. R. Bard Sales Value Proportion by Application in 2025
Table 91. C. R. Bard Sales Value Proportion by Geographic Area in 2025
Table 92. C. R. Bard Hemostats SWOT Analysis
Table 93. C. R. Bard Recent Developments
Table 94. The Medicines Company Corporation Information
Table 95. The Medicines Company Description and Major Businesses
Table 96. The Medicines Company Product Models, Descriptions and Specifications
Table 97. The Medicines Company Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 98. The Medicines Company Sales Value Proportion by Product in 2025
Table 99. The Medicines Company Sales Value Proportion by Application in 2025
Table 100. The Medicines Company Sales Value Proportion by Geographic Area in 2025
Table 101. The Medicines Company Hemostats SWOT Analysis
Table 102. The Medicines Company Recent Developments
Table 103. Anika Therapeutics Corporation Information
Table 104. Anika Therapeutics Description and Major Businesses
Table 105. Anika Therapeutics Product Models, Descriptions and Specifications
Table 106. Anika Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 107. Anika Therapeutics Recent Developments
Table 108. Advanced Medical Solutions Corporation Information
Table 109. Advanced Medical Solutions Description and Major Businesses
Table 110. Advanced Medical Solutions Product Models, Descriptions and Specifications
Table 111. Advanced Medical Solutions Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 112. Advanced Medical Solutions Recent Developments
Table 113. Integra LifeSciences Corporation Corporation Information
Table 114. Integra LifeSciences Corporation Description and Major Businesses
Table 115. Integra LifeSciences Corporation Product Models, Descriptions and Specifications
Table 116. Integra LifeSciences Corporation Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 117. Integra LifeSciences Corporation Recent Developments
Table 118. B Braun Melsungen AG Corporation Information
Table 119. B Braun Melsungen AG Description and Major Businesses
Table 120. B Braun Melsungen AG Product Models, Descriptions and Specifications
Table 121. B Braun Melsungen AG Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 122. B Braun Melsungen AG Recent Developments
Table 123. Gelita Medical GmbH Corporation Information
Table 124. Gelita Medical GmbH Description and Major Businesses
Table 125. Gelita Medical GmbH Product Models, Descriptions and Specifications
Table 126. Gelita Medical GmbH Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 127. Gelita Medical GmbH Recent Developments
Table 128. Equimedical Corporation Information
Table 129. Equimedical Description and Major Businesses
Table 130. Equimedical Product Models, Descriptions and Specifications
Table 131. Equimedical Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 132. Equimedical Recent Developments
Table 133. Vascular Solutions Corporation Information
Table 134. Vascular Solutions Description and Major Businesses
Table 135. Vascular Solutions Product Models, Descriptions and Specifications
Table 136. Vascular Solutions Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 137. Vascular Solutions Recent Developments
Table 138. Marine Polymer Technologies Corporation Information
Table 139. Marine Polymer Technologies Description and Major Businesses
Table 140. Marine Polymer Technologies Product Models, Descriptions and Specifications
Table 141. Marine Polymer Technologies Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 142. Marine Polymer Technologies Recent Developments
Table 143. Z-Medica, LLC Corporation Information
Table 144. Z-Medica, LLC Description and Major Businesses
Table 145. Z-Medica, LLC Product Models, Descriptions and Specifications
Table 146. Z-Medica, LLC Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 147. Z-Medica, LLC Recent Developments
Table 148. CryoLife Corporation Information
Table 149. CryoLife Description and Major Businesses
Table 150. CryoLife Product Models, Descriptions and Specifications
Table 151. CryoLife Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 152. CryoLife Recent Developments
Table 153. BioCer Entwicklungs-GmbH. Corporation Information
Table 154. BioCer Entwicklungs-GmbH. Description and Major Businesses
Table 155. BioCer Entwicklungs-GmbH. Product Models, Descriptions and Specifications
Table 156. BioCer Entwicklungs-GmbH. Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 157. BioCer Entwicklungs-GmbH. Recent Developments
Table 158. Biom'Up SAS Corporation Information
Table 159. Biom'Up SAS Description and Major Businesses
Table 160. Biom'Up SAS Product Models, Descriptions and Specifications
Table 161. Biom'Up SAS Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026)
Table 162. Biom'Up SAS Recent Developments
Table 163. Key Raw Materials Distribution
Table 164. Raw Materials Key Suppliers
Table 165. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 166. Milestones in Production Technology Evolution
Table 167. Distributors List
Table 168. Market Trends and Market Evolution
Table 169. Market Drivers and Opportunities
Table 170. Market Challenges, Risks, and Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Thrombin-Based Hemostats Product Picture
Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Gelatin Based Hemostats Product Picture
Figure 7. Collagen Based Hemostats Product Picture
Figure 8. Global Hemostats Market Size Growth Rate by Feature, 2021 vs 2025 vs 2032 (US$ Million)
Figure 9. Biodegradable Product Picture
Figure 10. Non-biodegradable Product Picture
Figure 11. Global Hemostats Market Size Growth Rate by Channel, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Online Sales Product Picture
Figure 13. Offline Sales Product Picture
Figure 14. Global Hemostats Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Prehospital Treatment
Figure 16. Hospital Treatment
Figure 17. Hemostats Report Years Considered
Figure 18. Global Hemostats Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Hemostats Revenue (US$ Million), 2021-2032
Figure 20. Global Hemostats Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Global Hemostats Revenue-Based Market Share by Region (2021-2032)
Figure 22. Global Hemostats Sales (K Pcs), 2021-2032
Figure 23. Global Hemostats Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Pcs)
Figure 24. Global Hemostats Sales Market Share by Region (2021-2032)
Figure 25. Top 5 and Top 10 Manufacturers Hemostats Sales Volume Market Share in 2025
Figure 26. Global Hemostats Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Thrombin-Based Hemostats Revenue-Based Market Share by Manufacturer in 2025
Figure 29. Oxidized Regenerated Cellulose Based Hemostats Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Combination Hemostats Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Gelatin Based Hemostats Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Collagen Based Hemostats Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Global Hemostats Sales Volume-Based Market Share by Type (2021-2032)
Figure 34. Global Hemostats Revenue-Based Market Share by Type (2021-2032)
Figure 35. Global Hemostats ASP by Type (US$/Pc), 2021-2032
Figure 36. Global Hemostats Sales Volume-Based Market Share by Feature (2021-2032)
Figure 37. Global Hemostats Revenue-Based Market Share by Feature (2021-2032)
Figure 38. Global Hemostats ASP by Feature (US$/Pc), 2021-2032
Figure 39. Global Hemostats Sales Volume-Based Market Share by Channel (2021-2032)
Figure 40. Global Hemostats Revenue-Based Market Share by Channel (2021-2032)
Figure 41. Global Hemostats ASP by Channel (US$/Pc), 2021-2032
Figure 42. Global Hemostats Sales Market Share by Application (2021-2032)
Figure 43. Global Hemostats Revenue-Based Market Share by Application (2021-2032)
Figure 44. Global Hemostats ASP by Application (US$/Pc), 2021-2032
Figure 45. North America Hemostats Sales YoY (K Pcs), 2021-2032
Figure 46. North America Hemostats Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2025
Figure 48. North America Hemostats Sales Volume (K Pcs) by Application (2021-2032)
Figure 49. North America Hemostats Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. US Hemostats Revenue (US$ Million), 2021-2032
Figure 51. Canada Hemostats Revenue (US$ Million), 2021-2032
Figure 52. Mexico Hemostats Revenue (US$ Million), 2021-2032
Figure 53. Europe Hemostats Sales YoY (K Pcs), 2021-2032
Figure 54. Europe Hemostats Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2025
Figure 56. Europe Hemostats Sales Volume (K Pcs) by Application (2021-2032)
Figure 57. Europe Hemostats Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Germany Hemostats Revenue (US$ Million), 2021-2032
Figure 59. France Hemostats Revenue (US$ Million), 2021-2032
Figure 60. U.K. Hemostats Revenue (US$ Million), 2021-2032
Figure 61. Italy Hemostats Revenue (US$ Million), 2021-2032
Figure 62. Russia Hemostats Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Hemostats Sales YoY (K Pcs), 2021-2032
Figure 64. Asia-Pacific Hemostats Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Hemostats Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Hemostats Sales Volume (K Pcs) by Application (2021-2032)
Figure 67. Asia-Pacific Hemostats Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Indonesia Hemostats Revenue (US$ Million), 2021-2032
Figure 69. Japan Hemostats Revenue (US$ Million), 2021-2032
Figure 70. South Korea Hemostats Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Hemostats Revenue (US$ Million), 2021-2032
Figure 72. India Hemostats Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Hemostats Sales YoY (K Pcs), 2021-2032
Figure 74. Central and South America Hemostats Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Hemostats Sales Volume (K Pcs) by Application (2021-2032)
Figure 77. Central and South America Hemostats Sales Revenue (US$ Million) by Application (2021-2032)
Figure 78. Brazil Hemostats Revenue (US$ Million), 2021-2032
Figure 79. Argentina Hemostats Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Hemostats Sales YoY (K Pcs), 2021-2032
Figure 81. Middle East and Africa Hemostats Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Hemostats Sales Volume (K Pcs) by Application (2021-2032)
Figure 84. Middle East and Africa Hemostats Sales Revenue (US$ Million) by Application (2021-2032)
Figure 85. GCC Countries Hemostats Revenue (US$ Million), 2021-2032
Figure 86. Turkey Hemostats Revenue (US$ Million), 2021-2032
Figure 87. Egypt Hemostats Revenue (US$ Million), 2021-2032
Figure 88. South Africa Hemostats Revenue (US$ Million), 2021-2032
Figure 89. Hemostats Industry Chain Mapping
Figure 90. Regional Hemostats Manufacturing Base Distribution (%)
Figure 91. Global Hemostats Production Market Share by Region (2021-2032)
Figure 92. Hemostats Production Process
Figure 93. Regional Hemostats Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hemostats market?
The top companies in the global Hemostats market are Ethicon、Pfizer、Baxter International Inc..
Which region is expected to have the highest market share?
What was the global market size of Hemostats in 2026?
What was the global market size of Hemostats in 2032?
What is the annual compound growth rate of the global Hemostats market size from 2026 to 2032?
Related Reports
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 106
USD 2900.00
(Single User License)
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-17
Pages: 182
USD 5600.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
USD 4250.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 106
USD 2900.00 (Single User License)Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-17
Pages: 182
USD 5600.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now